Wegovy: Why half of those taking it stop within a year, and what happens when they do
Despite the effectiveness of the newer generation of anti-obesity drugs—called GLP-1 receptor agonists—few can tolerate them in the long run. A new study, published in the journal Obesity, reveals that of people prescribed ...
Dec 24, 2023
0
1